Oramed Pharmaceuticals
ORMP
#9231
Rank
โ‚น15.50 B
Marketcap
โ‚น372.85
Share price
-0.75%
Change (1 day)
84.35%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): โ‚น5.55 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of โ‚น5.84 Billion, an increase over its 2024 earnings that were of -โ‚น1.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น5.55 B-4.97%
2025 โ‚น5.84 B-513.21%
2024 -โ‚น1.42 Billion-311.47%
2023 โ‚น0.66 B-119.45%
2022 -โ‚น3.45 Billion39.17%
2021 -โ‚น2.48 Billion73.93%
2020 -โ‚น1.43 Billion18.53%
2019 -โ‚น1.2 Billion-16.62%
2018 -โ‚น1.44 Billion38.32%
2017 -โ‚น1.04 Billion12.51%
2016 -โ‚น0.93 Billion25.01%
2015 -โ‚น0.74 Billion18.18%
2014 -โ‚น0.63 Billion39.72%
2013 -โ‚น0.45 Billion46.4%
2012 -โ‚น0.31 Billion128.32%
2011 -โ‚น0.14 Billion-51.47%
2010 -โ‚น0.28 Billion35.21%
2009 -โ‚น0.21 Billion
2007 -โ‚น0.33 Billion607.04%
2006 -โ‚น45.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚น2.158 T 36,485.33%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น731.43 B 12,296.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น42.01 Billion-811.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น5.74 Billion-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น3.27 B-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel